Hualan Biological Engineering
002007.SZ
#3445
Rank
S$5.16 B
Marketcap
S$2.83
Share price
-0.19%
Change (1 day)
-8.73%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2025 (TTM): S$0.25 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are S$0.63 Billion. In 2024 the company made an earning of S$0.24 Billion a decrease over its 2023 earnings that were of S$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.25 B6.65%
2024 S$0.24 B-36.03%
2023 S$0.37 B39.14%
2022 S$0.27 B-19.27%
2021 S$0.33 B-17.84%
2020 S$0.41 B37.54%
2019 S$0.29 B11.56%
2018 S$0.26 B50.74%
2017 S$0.17 B1.03%
2016 S$0.17 B23.54%
2015 S$0.14 B8.4%
2014 S$0.13 B10.91%
2013 S$0.11 B54.55%
2012 S$76.74 M-17.1%
2011 S$92.57 M-41.28%
2010 S$0.15 B6.13%
2009 S$0.14 B261.35%
2008 S$41.1 M85.72%
2007 S$22.13 M49.33%
2006 S$14.82 M56.91%
2005 S$9.44 M34.29%
2004 S$7.03 M